Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines

Cancer Research

Volumn 58, Issue 9, 1998, Pages 2014-2019

  Kondo, Keiichi ^a   Kohno, Nobuoki ^a   Yokoyama, Akihito ^a   Hiwada, Kunio ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BUTYRIC ACID; MUCIN; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL AGGREGATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DOSE RESPONSE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ALPHA CATENIN; BETA CATENIN; BLOTTING, NORTHERN; BREAST NEOPLASMS; BUTYRIC ACID; BUTYRIC ACIDS; CA-15-3 ANTIGEN; CADHERINS; CELL ADHESION; CELL DIVISION; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; LEUCINE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0032080901     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
2. Behrens, J., Mareel, M. M., van Roy, F. M., and Birchmeier, W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108: 2435-2447, 1989.
3. Shimoyama, Y., Nagafuchi, A., Fujita, S., Gotoh, M., Takeichi, M., Tsukita, S., and Hirohashi, S. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res., 52: 5770-5774, 1992.
4. Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quintanilla, M., and Cano, A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol., 142: 987-993, 1993.
5. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., and Höfler, H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54: 3845-3852, 1994.
6. Gum, J. R. Mucin genes and the proteins they encode: structure, diversity, and regulation. Am. J. Respir. Cell Mol. Biol., 7: 557-564, 1992.
7. Hilkens, J., Ligtenberg, M. J. L., Vos, H. L., and Litvinov, S. V. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci., 17: 359-363, 1992.
8. Apostolopoulos, V., Xing, P. X., Trapani, J. A., and McKenzie, I. F. C. Production of anti-breast cancer monoclonal antibodies using a glutathione S-transferase-MUC1 bacterial fusion protein. Br. J. Cancer, 67: 713-720, 1993.
9. Gimmi, C. D., Morrison, B. W., Mainprice, B. A., Gribben, J. G., Boussiotis, V. A., Freeman, G. J., Park, S. Y. L., Watanabe, M., Gong, J., Hayes, D. F., Kufe, D. W., and Nadler, L. M. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat. Med., 2: 1367-1370, 1996.
10. Hamada, H., Kohno, N., and Hiwada, K. A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma. Jpn. J. Cancer Res., 85: 211-219, 1994.
11. Kruh, J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem., 42: 65-82, 1982.
12. Abe, M., and Kufe, D. W. Effect of sodium butyrate on human breast carcinoma (MCF-7) cellular proliferation, morphology, and CEA production. Breast Cancer Res. Treat., 4: 269-274, 1984.
13. Miller, A. A., Kurschel, E., Osieka, R., and Schmidt, C. G. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Cancer Clin. Oncol., 23: 1283-1287, 1987.
14. Ligtenberg, M. J. L., Buijs, F., Vos, H. L., and Hilkens, J. Suppression of cellular aggregation by high levels of episialin. Cancer Res., 52: 2318-2324, 1992.
15. Yamane, M., Nishiki, M., Kataoka, T., Kishi, N., Amano, K., Nakagawa, K., Okumichi, T., Naito, M., Ito, A., and Ezaki, H. Establishment and characterization of new cell line (YMB-1) derived from human breast carcinoma. Hiroshima J. Med. Sci., 33: 715-720, 1984.
16. Fujioka, S., Kohno, N., and Hiwada, K. Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S. Jpn. J. Cancer Res., 86: 368-373, 1995.
17. Lan, M. S., Batra, S. K., Qi, W. N., Metzgar, R. S., and Hollingsworth, M. A. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J. Biol. Chem., 265: 15294-15299, 1990.
18. Stern, L., Palatsides, M., de Kretser, T., and Ford, M. Expression of the tumor-associated mucin MUC1 in an ovarian tumor cell line. Int. J. Cancer, 50: 783-790, 1992.
19. Fujino, S., Yokoyama, A., Kohno, N., and Hiwada, K. Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol., 14: 508-515, 1996.
20. Behrens, J., Vakaet, L., Friis, R., Winterhager, E., van Roy, F., Mareel, M. M., and Birchmeier, W. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol., 120: 757-766, 1993.
21. Oyama, T., Kanai, Y., Ochiai, A., Akimoto, S., Oda, T., Yanagihara, K., Nagafuchi, A., Tsukita, S., Shibamoto, S., Ito, F., Takeichi, M., Matsuda, H., and Hirohashi, S. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res., 54: 6282-6287, 1994.
22. Balsamo, J., Leung, T., Ernst, H., Zanin, M. K. B., Hoffman, S., and Lilien, J. Regulated binding of a PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of β-catenin. J. Cell Biol., 134: 801-813, 1996.
23. Wesseling, J., van der Valk, S. W., Vos, H. L., Sonnenberg, A., and Hilkens, J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell Biol., 129: 255-265, 1995.
24. 1 progression in chemically transformed mouse fibroblasts BP-A31. J. Cell. Physiol., 145: 46-52, 1990.
25. Russo, G. L., Pietra, V. D., Mercurio, C., Ragione, F. D., Marshak, D. R., Oliva, A., and Zappia, V. Down-regulation of protein kinase CKII activity by sodium butyrate. Biochem. Biophys. Res. Commun., 233: 673-677, 1997.
26. Wright, J. A. Morphology and growth rate changes in Chinese hamster cells cultured in presence of sodium butyrate. Exp. Cell Res., 78: 456-460, 1973.
27. Taylor-Papadimitriou, J., Stewart, L., Burchell, J., and Beverley, P. The polymorphic epithelial mucin as a target for immunotherapy. Ann. N. Y. Acad. Sci., 690: 69-79, 1993.
28. Zhang, S., Graeber, L. A., Helling, F., Ragupathi, G., Adluri, S., Lloyd, K. O., and Livingston, P. O. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res., 56: 3315-3319, 1996.